Mark A Exley

Title: The Innovations of Mark A Exley

Introduction

Mark A Exley is a prominent inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of medical technology, particularly in the development of T cell receptors for treating mixed lineage leukemia. With a total of 14 patents to his name, Exley's work has the potential to impact cancer treatment significantly.

Latest Patents

Exley's latest patents focus on T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides. These patents provide TCRs that can bind to MLL phosphopeptides and MHC complexes. The inventions include cells and pharmaceutical compositions that comprise these TCRs, as well as nucleic acids encoding them. Additionally, Exley has developed expression vectors and host cells for producing these TCRs, along with methods for treating subjects using these innovative receptors.

Career Highlights

Throughout his career, Mark A Exley has worked with notable organizations such as Immunologic Pharmaceutical Corporation and Beth Israel Deaconess Medical Center, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Exley has collaborated with esteemed colleagues, including Stephen P Powers and Philip A Swain. These partnerships have further enhanced his research and development efforts in the medical technology sector.

Conclusion

Mark A Exley's contributions to the field of medical technology through his innovative patents and collaborations highlight his dedication to advancing cancer treatment. His work continues to pave the way for new therapeutic approaches in the fight against leukemia.